Clicky

Monday, November 2, 2026

IPO

New listings and registration statements

GridAI Technologies Corp. registers S-1 filing for IPO

GridAI Technologies Corp. has registered its S-1 filing, marking a significant step towards its IPO and impacting the electric services industry.

Dermata Therapeutics receives effectiveness for S-3 filing

Dermata Therapeutics, Inc. secures effectiveness for its S-3 registration statement, paving the way for future capital-raising efforts.

Andean Silver Ltd Secures SEC Effectiveness for F-6 Filing

Andean Silver Ltd has gained SEC effectiveness for its F-6 filing, marking a significant step in its growth strategy in the mining sector.

Equity Bancshares registers S-4 filing for strategic growth

Equity Bancshares Inc registers its S-4 filing, signaling growth and expansion in the state commercial banking sector, impacting industry dynamics.

CitroTech Inc. secures SEC approval for S-1 registration

CitroTech Inc. has received SEC approval for its S-1 registration, paving the way for new capital-raising efforts in the chemicals sector.

Applied Energetics Receives Effectiveness for S-3 Registration

Applied Energetics, Inc. has received effectiveness for its S-3 registration statement, enhancing its capital-raising capabilities.

SKYX Platforms Corp. secures SEC approval for S-3 offering

SKYX Platforms Corp. gains SEC approval for its S-3 registration, enhancing its ability to raise capital in the electric lighting and wiring equipment sector.

MN8 Energy secures SEC approval for capital raise

MN8 Energy Holdings LLC receives SEC approval for S-4 registration, allowing for planned capital raise, signaling growth in the electric services sector.

DarkHorse Technologies gets SEC approval for S-3 offering

DarkHorse Technologies Inc. secures SEC approval for its S-3 registration, enabling public securities offerings and enhancing its market position.

GT Biopharma registers S-1 filing, paving way for funding

GT Biopharma, Inc. has registered its S-1 filing, a significant step for its capital-raising efforts in the pharmaceutical preparations sector.

Valion Bio Announces Effectiveness of Recent Filing

Valion Bio, Inc. receives notice of effectiveness for its recent filing, marking a significant step forward in the pharmaceutical preparations sector.

Valion Bio secures effectiveness for S-3 registration statement

Valion Bio, Inc. has secured effectiveness for its S-3 registration statement, positioning the company for growth in the pharmaceutical preparations industry.

HMH Holding Inc Receives Notice of Effectiveness for Filing

HMH Holding Inc has received a notice of effectiveness for its recent filing, indicating regulatory compliance and readiness for growth in the oil and gas machinery sector.

Klabin S.A./ADR Receives Effectiveness for SEC Filing

Klabin S.A./ADR has received effectiveness for its SEC filing, marking a significant step for the company and the industry.

Guggenheim Defined Portfolios, Series 2634 Receives Effectiveness

Guggenheim Defined Portfolios, Series 2634 has achieved effectiveness for its registration statement, paving the way for new investment opportunities.

Youlife Group Inc. secures effectiveness for F-3 registration

Youlife Group Inc. gains effectiveness for its F-3 registration, allowing for new securities offerings, impacting the educational services sector.

Capital Group Multi-Asset Income ETF Receives Effectiveness

Capital Group Multi-Asset Income ETF gains effectiveness for public share offerings, marking a significant step in the investment sector.

Cubebio Co., Ltd Announces Effectiveness of SEC Filing

Cubebio Co., Ltd confirms the effectiveness of its SEC filing, a key development for the surgical and medical instruments industry.

CEMIG/ADR Receives SEC Effectiveness for Recent Filing

CEMIG/ADR secures SEC effectiveness for its recent filing, signaling readiness for future initiatives in the energy sector.

FibroBiologics Receives Effective Registration for Securities

FibroBiologics, Inc. has received effective registration for its securities, a crucial step for funding and growth in the pharmaceutical preparations sector.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →